nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—ACY1—prostate gland—urinary bladder cancer	0.0198	0.0897	CbGeAlD
Acetylcysteine—GRIN2D—prostate gland—urinary bladder cancer	0.014	0.0635	CbGeAlD
Acetylcysteine—CHUK—prostate gland—urinary bladder cancer	0.0136	0.0619	CbGeAlD
Acetylcysteine—ACY1—renal system—urinary bladder cancer	0.0135	0.0611	CbGeAlD
Acetylcysteine—ACY1—female reproductive system—urinary bladder cancer	0.0108	0.0489	CbGeAlD
Acetylcysteine—CHUK—epithelium—urinary bladder cancer	0.01	0.0455	CbGeAlD
Acetylcysteine—CHUK—renal system—urinary bladder cancer	0.0093	0.0422	CbGeAlD
Acetylcysteine—IKBKB—prostate gland—urinary bladder cancer	0.00928	0.0421	CbGeAlD
Acetylcysteine—GSS—prostate gland—urinary bladder cancer	0.00911	0.0413	CbGeAlD
Acetylcysteine—SLC7A11—smooth muscle tissue—urinary bladder cancer	0.00796	0.0361	CbGeAlD
Acetylcysteine—GSS—seminal vesicle—urinary bladder cancer	0.0077	0.0349	CbGeAlD
Acetylcysteine—SLC7A11—renal system—urinary bladder cancer	0.00766	0.0347	CbGeAlD
Acetylcysteine—CHUK—female reproductive system—urinary bladder cancer	0.00745	0.0338	CbGeAlD
Acetylcysteine—IKBKB—smooth muscle tissue—urinary bladder cancer	0.00657	0.0298	CbGeAlD
Acetylcysteine—GSS—smooth muscle tissue—urinary bladder cancer	0.00645	0.0292	CbGeAlD
Acetylcysteine—IKBKB—urethra—urinary bladder cancer	0.00621	0.0282	CbGeAlD
Acetylcysteine—GSS—renal system—urinary bladder cancer	0.00621	0.0281	CbGeAlD
Acetylcysteine—SLC7A11—female reproductive system—urinary bladder cancer	0.00613	0.0278	CbGeAlD
Acetylcysteine—GSS—urethra—urinary bladder cancer	0.0061	0.0276	CbGeAlD
Acetylcysteine—GRIN2A—vagina—urinary bladder cancer	0.00514	0.0233	CbGeAlD
Acetylcysteine—IKBKB—female reproductive system—urinary bladder cancer	0.00506	0.023	CbGeAlD
Acetylcysteine—GSS—female reproductive system—urinary bladder cancer	0.00497	0.0225	CbGeAlD
Acetylcysteine—IKBKB—vagina—urinary bladder cancer	0.00458	0.0208	CbGeAlD
Acetylcysteine—SLCO1B1—renal system—urinary bladder cancer	0.00456	0.0207	CbGeAlD
Acetylcysteine—GSS—vagina—urinary bladder cancer	0.0045	0.0204	CbGeAlD
Acetylcysteine—CHUK—lymph node—urinary bladder cancer	0.00436	0.0198	CbGeAlD
Acetylcysteine—SLCO1B1—female reproductive system—urinary bladder cancer	0.00365	0.0166	CbGeAlD
Acetylcysteine—IKBKB—lymph node—urinary bladder cancer	0.00296	0.0134	CbGeAlD
Acetylcysteine—GSS—lymph node—urinary bladder cancer	0.00291	0.0132	CbGeAlD
Acetylcysteine—Dermatitis—Valrubicin—urinary bladder cancer	0.00196	0.00787	CcSEcCtD
Acetylcysteine—Dyspnoea—Mitomycin—urinary bladder cancer	0.00191	0.00767	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.0019	0.00765	CcSEcCtD
Acetylcysteine—Somnolence—Mitomycin—urinary bladder cancer	0.0019	0.00765	CcSEcCtD
Acetylcysteine—Nausea—Valrubicin—urinary bladder cancer	0.00184	0.00742	CcSEcCtD
Acetylcysteine—Face oedema—Gemcitabine—urinary bladder cancer	0.00178	0.00715	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.00177	0.00713	CcSEcCtD
Acetylcysteine—Body temperature increased—Mitomycin—urinary bladder cancer	0.00169	0.0068	CcSEcCtD
Acetylcysteine—Face oedema—Cisplatin—urinary bladder cancer	0.00166	0.00666	CcSEcCtD
Acetylcysteine—Stomatitis—Thiotepa—urinary bladder cancer	0.00164	0.00661	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—urinary bladder cancer	0.00164	0.0066	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00162	0.00653	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.00162	0.00651	CcSEcCtD
Acetylcysteine—Bronchospasm—Gemcitabine—urinary bladder cancer	0.00156	0.0063	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—urinary bladder cancer	0.00155	0.00622	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.00153	0.00617	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—urinary bladder cancer	0.00152	0.0061	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—urinary bladder cancer	0.00143	0.00576	CcSEcCtD
Acetylcysteine—Dizziness—Mitomycin—urinary bladder cancer	0.00141	0.00569	CcSEcCtD
Acetylcysteine—Cardiac disorder—Thiotepa—urinary bladder cancer	0.0014	0.00565	CcSEcCtD
Acetylcysteine—Stomatitis—Gemcitabine—urinary bladder cancer	0.00138	0.00556	CcSEcCtD
Acetylcysteine—Angiopathy—Thiotepa—urinary bladder cancer	0.00137	0.00553	CcSEcCtD
Acetylcysteine—Immune system disorder—Thiotepa—urinary bladder cancer	0.00137	0.0055	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00136	0.00549	CcSEcCtD
Acetylcysteine—Sweating—Gemcitabine—urinary bladder cancer	0.00136	0.00547	CcSEcCtD
Acetylcysteine—Vomiting—Mitomycin—urinary bladder cancer	0.00136	0.00547	CcSEcCtD
Acetylcysteine—Stomatitis—Fluorouracil—urinary bladder cancer	0.00136	0.00547	CcSEcCtD
Acetylcysteine—Rash—Mitomycin—urinary bladder cancer	0.00135	0.00543	CcSEcCtD
Acetylcysteine—Dermatitis—Mitomycin—urinary bladder cancer	0.00135	0.00542	CcSEcCtD
Acetylcysteine—Bronchospasm—Etoposide—urinary bladder cancer	0.00134	0.00538	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—urinary bladder cancer	0.00133	0.00533	CcSEcCtD
Acetylcysteine—Erythema—Thiotepa—urinary bladder cancer	0.00132	0.0053	CcSEcCtD
Acetylcysteine—Stomatitis—Cisplatin—urinary bladder cancer	0.00129	0.00519	CcSEcCtD
Acetylcysteine—Nausea—Mitomycin—urinary bladder cancer	0.00127	0.00511	CcSEcCtD
Acetylcysteine—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00126	0.00508	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—urinary bladder cancer	0.00124	0.005	CcSEcCtD
Acetylcysteine—Pharyngitis—Fluorouracil—urinary bladder cancer	0.00124	0.005	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—urinary bladder cancer	0.00123	0.00494	CcSEcCtD
Acetylcysteine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00118	0.00475	CcSEcCtD
Acetylcysteine—Stomatitis—Etoposide—urinary bladder cancer	0.00118	0.00475	CcSEcCtD
Acetylcysteine—Angiopathy—Gemcitabine—urinary bladder cancer	0.00116	0.00465	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—urinary bladder cancer	0.00115	0.00463	CcSEcCtD
Acetylcysteine—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00115	0.00463	CcSEcCtD
Acetylcysteine—Cough—Thiotepa—urinary bladder cancer	0.00115	0.00463	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00115	0.00462	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00111	0.00448	CcSEcCtD
Acetylcysteine—Erythema—Gemcitabine—urinary bladder cancer	0.00111	0.00446	CcSEcCtD
Acetylcysteine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.0011	0.00443	CcSEcCtD
Acetylcysteine—Flushing—Cisplatin—urinary bladder cancer	0.0011	0.00443	CcSEcCtD
Acetylcysteine—Erythema—Fluorouracil—urinary bladder cancer	0.00109	0.00439	CcSEcCtD
Acetylcysteine—Immune system disorder—Cisplatin—urinary bladder cancer	0.00107	0.00431	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00107	0.0043	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—urinary bladder cancer	0.00105	0.00424	CcSEcCtD
Acetylcysteine—Tachycardia—Thiotepa—urinary bladder cancer	0.00105	0.00422	CcSEcCtD
Acetylcysteine—Skin disorder—Thiotepa—urinary bladder cancer	0.00104	0.0042	CcSEcCtD
Acetylcysteine—Erythema—Cisplatin—urinary bladder cancer	0.00103	0.00416	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—urinary bladder cancer	0.00101	0.00406	CcSEcCtD
Acetylcysteine—Cardiac disorder—Etoposide—urinary bladder cancer	0.00101	0.00406	CcSEcCtD
Acetylcysteine—Angiopathy—Etoposide—urinary bladder cancer	0.000986	0.00397	CcSEcCtD
Acetylcysteine—Immune system disorder—Etoposide—urinary bladder cancer	0.000982	0.00395	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00098	0.00394	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—urinary bladder cancer	0.000976	0.00393	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—urinary bladder cancer	0.000974	0.00392	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000973	0.00391	CcSEcCtD
Acetylcysteine—Cough—Gemcitabine—urinary bladder cancer	0.000967	0.00389	CcSEcCtD
Acetylcysteine—Somnolence—Thiotepa—urinary bladder cancer	0.000956	0.00385	CcSEcCtD
Acetylcysteine—Dyspepsia—Thiotepa—urinary bladder cancer	0.000947	0.00381	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000937	0.00377	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000928	0.00374	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00091	0.00366	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000905	0.00364	CcSEcCtD
Acetylcysteine—Oedema—Gemcitabine—urinary bladder cancer	0.000905	0.00364	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—urinary bladder cancer	0.000903	0.00363	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000889	0.00358	CcSEcCtD
Acetylcysteine—Oedema—Fluorouracil—urinary bladder cancer	0.000889	0.00358	CcSEcCtD
Acetylcysteine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000879	0.00354	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000874	0.00352	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000873	0.00351	CcSEcCtD
Acetylcysteine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000868	0.00349	CcSEcCtD
Acetylcysteine—Urticaria—Thiotepa—urinary bladder cancer	0.000854	0.00344	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—urinary bladder cancer	0.00085	0.00342	CcSEcCtD
Acetylcysteine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00085	0.00342	CcSEcCtD
Acetylcysteine—Hypotension—Gemcitabine—urinary bladder cancer	0.000845	0.0034	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000843	0.00339	CcSEcCtD
Acetylcysteine—Oedema—Cisplatin—urinary bladder cancer	0.000843	0.00339	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000842	0.00339	CcSEcCtD
Acetylcysteine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000832	0.00335	CcSEcCtD
Acetylcysteine—Hypotension—Fluorouracil—urinary bladder cancer	0.000831	0.00334	CcSEcCtD
Acetylcysteine—Cough—Etoposide—urinary bladder cancer	0.000826	0.00332	CcSEcCtD
Acetylcysteine—Tachycardia—Cisplatin—urinary bladder cancer	0.000823	0.00331	CcSEcCtD
Acetylcysteine—Skin disorder—Cisplatin—urinary bladder cancer	0.000819	0.0033	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000815	0.00328	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—urinary bladder cancer	0.000814	0.00327	CcSEcCtD
Acetylcysteine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000806	0.00325	CcSEcCtD
Acetylcysteine—Somnolence—Gemcitabine—urinary bladder cancer	0.000804	0.00324	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.0008	0.00322	CcSEcCtD
Acetylcysteine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000793	0.00319	CcSEcCtD
Acetylcysteine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000792	0.00319	CcSEcCtD
Acetylcysteine—Somnolence—Fluorouracil—urinary bladder cancer	0.000791	0.00318	CcSEcCtD
Acetylcysteine—Hypotension—Cisplatin—urinary bladder cancer	0.000788	0.00317	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000788	0.00317	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—urinary bladder cancer	0.000787	0.00317	CcSEcCtD
Acetylcysteine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000783	0.00315	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000781	0.00314	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000772	0.00311	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000768	0.00309	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—urinary bladder cancer	0.000761	0.00306	CcSEcCtD
Acetylcysteine—Pruritus—Thiotepa—urinary bladder cancer	0.000761	0.00306	CcSEcCtD
Acetylcysteine—Tachycardia—Etoposide—urinary bladder cancer	0.000754	0.00303	CcSEcCtD
Acetylcysteine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000752	0.00302	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—urinary bladder cancer	0.00075	0.00302	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000747	0.003	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000729	0.00293	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000728	0.00293	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—urinary bladder cancer	0.000725	0.00292	CcSEcCtD
Acetylcysteine—Hypotension—Etoposide—urinary bladder cancer	0.000722	0.0029	CcSEcCtD
Acetylcysteine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000715	0.00288	CcSEcCtD
Acetylcysteine—Dizziness—Thiotepa—urinary bladder cancer	0.000711	0.00286	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—urinary bladder cancer	0.000707	0.00285	CcSEcCtD
Acetylcysteine—Urticaria—Fluorouracil—urinary bladder cancer	0.000707	0.00284	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—urinary bladder cancer	0.000704	0.00283	CcSEcCtD
Acetylcysteine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000703	0.00283	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—urinary bladder cancer	0.000695	0.0028	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—urinary bladder cancer	0.000689	0.00277	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—urinary bladder cancer	0.000687	0.00276	CcSEcCtD
Acetylcysteine—Vomiting—Thiotepa—urinary bladder cancer	0.000684	0.00275	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—urinary bladder cancer	0.000679	0.00273	CcSEcCtD
Acetylcysteine—Rash—Thiotepa—urinary bladder cancer	0.000678	0.00273	CcSEcCtD
Acetylcysteine—Dermatitis—Thiotepa—urinary bladder cancer	0.000677	0.00273	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000667	0.00268	CcSEcCtD
Acetylcysteine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000667	0.00268	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—urinary bladder cancer	0.000662	0.00266	CcSEcCtD
Acetylcysteine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000655	0.00264	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—urinary bladder cancer	0.000651	0.00262	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000646	0.0026	CcSEcCtD
Acetylcysteine—Pruritus—Gemcitabine—urinary bladder cancer	0.00064	0.00258	CcSEcCtD
Acetylcysteine—Nausea—Thiotepa—urinary bladder cancer	0.000639	0.00257	CcSEcCtD
Acetylcysteine—Pruritus—Fluorouracil—urinary bladder cancer	0.000629	0.00253	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000628	0.00253	CcSEcCtD
Acetylcysteine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000621	0.0025	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—urinary bladder cancer	0.000614	0.00247	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—urinary bladder cancer	0.000612	0.00246	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—urinary bladder cancer	0.000611	0.00246	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000605	0.00243	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000604	0.00243	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—urinary bladder cancer	0.000602	0.00242	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—urinary bladder cancer	0.000591	0.00238	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000588	0.00237	CcSEcCtD
Acetylcysteine—Dizziness—Fluorouracil—urinary bladder cancer	0.000588	0.00237	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000587	0.00236	CcSEcCtD
Acetylcysteine—Vomiting—Gemcitabine—urinary bladder cancer	0.000575	0.00231	CcSEcCtD
Acetylcysteine—Rash—Gemcitabine—urinary bladder cancer	0.00057	0.0023	CcSEcCtD
Acetylcysteine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00057	0.00229	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000569	0.00229	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—urinary bladder cancer	0.000567	0.00228	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000566	0.00228	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—urinary bladder cancer	0.000566	0.00228	CcSEcCtD
Acetylcysteine—Vomiting—Fluorouracil—urinary bladder cancer	0.000565	0.00228	CcSEcCtD
Acetylcysteine—Rash—Fluorouracil—urinary bladder cancer	0.000561	0.00226	CcSEcCtD
Acetylcysteine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00056	0.00225	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00056	0.00225	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—urinary bladder cancer	0.000553	0.00222	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—urinary bladder cancer	0.00055	0.00222	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000549	0.00221	CcSEcCtD
Acetylcysteine—Pruritus—Etoposide—urinary bladder cancer	0.000546	0.0022	CcSEcCtD
Acetylcysteine—Nausea—Gemcitabine—urinary bladder cancer	0.000537	0.00216	CcSEcCtD
Acetylcysteine—Vomiting—Cisplatin—urinary bladder cancer	0.000536	0.00216	CcSEcCtD
Acetylcysteine—Rash—Cisplatin—urinary bladder cancer	0.000532	0.00214	CcSEcCtD
Acetylcysteine—Dermatitis—Cisplatin—urinary bladder cancer	0.000531	0.00214	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—urinary bladder cancer	0.000531	0.00213	CcSEcCtD
Acetylcysteine—Nausea—Fluorouracil—urinary bladder cancer	0.000528	0.00213	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—urinary bladder cancer	0.000523	0.00211	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000523	0.00211	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000512	0.00206	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—urinary bladder cancer	0.000511	0.00206	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000509	0.00205	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000508	0.00205	CcSEcCtD
Acetylcysteine—Nausea—Cisplatin—urinary bladder cancer	0.000501	0.00202	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—urinary bladder cancer	0.000495	0.00199	CcSEcCtD
Acetylcysteine—Vomiting—Etoposide—urinary bladder cancer	0.000491	0.00198	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—urinary bladder cancer	0.000491	0.00198	CcSEcCtD
Acetylcysteine—Rash—Etoposide—urinary bladder cancer	0.000487	0.00196	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—urinary bladder cancer	0.000487	0.00196	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000479	0.00193	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—urinary bladder cancer	0.000476	0.00191	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000466	0.00188	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—urinary bladder cancer	0.000463	0.00186	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000463	0.00186	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—urinary bladder cancer	0.000459	0.00185	CcSEcCtD
Acetylcysteine—Skin disorder—Methotrexate—urinary bladder cancer	0.000449	0.00181	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000449	0.0018	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000447	0.0018	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—urinary bladder cancer	0.00044	0.00177	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000433	0.00174	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—urinary bladder cancer	0.000433	0.00174	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—urinary bladder cancer	0.000432	0.00174	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000431	0.00174	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—urinary bladder cancer	0.000428	0.00172	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—urinary bladder cancer	0.000426	0.00171	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—urinary bladder cancer	0.000423	0.0017	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—urinary bladder cancer	0.000421	0.00169	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000419	0.00168	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000415	0.00167	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000412	0.00166	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—urinary bladder cancer	0.000411	0.00166	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000407	0.00164	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—urinary bladder cancer	0.000405	0.00163	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—urinary bladder cancer	0.000401	0.00161	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000401	0.00161	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000399	0.00161	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—urinary bladder cancer	0.000394	0.00159	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000391	0.00157	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000389	0.00157	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000387	0.00156	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000386	0.00155	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—urinary bladder cancer	0.000385	0.00155	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000381	0.00153	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—urinary bladder cancer	0.000374	0.00151	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000374	0.0015	CcSEcCtD
Acetylcysteine—Urticaria—Methotrexate—urinary bladder cancer	0.000368	0.00148	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000366	0.00147	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000357	0.00144	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—urinary bladder cancer	0.000356	0.00143	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000353	0.00142	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000346	0.00139	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—urinary bladder cancer	0.000344	0.00138	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000342	0.00138	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000341	0.00137	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—urinary bladder cancer	0.000327	0.00132	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000319	0.00128	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—urinary bladder cancer	0.000318	0.00128	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000317	0.00127	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—urinary bladder cancer	0.000306	0.00123	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—urinary bladder cancer	0.000306	0.00123	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000295	0.00119	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—urinary bladder cancer	0.000294	0.00118	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—urinary bladder cancer	0.000292	0.00117	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—urinary bladder cancer	0.000291	0.00117	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—urinary bladder cancer	0.000286	0.00115	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—urinary bladder cancer	0.000283	0.00114	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—urinary bladder cancer	0.000275	0.00111	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—urinary bladder cancer	0.000275	0.00111	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—urinary bladder cancer	0.000273	0.0011	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—urinary bladder cancer	0.000273	0.0011	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—urinary bladder cancer	0.000265	0.00107	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—urinary bladder cancer	0.000257	0.00103	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—urinary bladder cancer	0.000255	0.00102	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—urinary bladder cancer	0.000253	0.00102	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000252	0.00102	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—urinary bladder cancer	0.000238	0.000958	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB4—HRAS—urinary bladder cancer	0.00011	0.000208	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—urinary bladder cancer	0.00011	0.000208	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL2—urinary bladder cancer	0.00011	0.000207	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—urinary bladder cancer	0.000109	0.000206	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—urinary bladder cancer	0.000109	0.000205	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.000109	0.000205	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—KRAS—urinary bladder cancer	0.000109	0.000204	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—ERBB2—urinary bladder cancer	0.000108	0.000204	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.000108	0.000203	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—EGFR—urinary bladder cancer	0.000108	0.000203	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HDAC4—urinary bladder cancer	0.000108	0.000203	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—urinary bladder cancer	0.000108	0.000203	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—KRAS—urinary bladder cancer	0.000106	0.0002	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—KRAS—urinary bladder cancer	0.000106	0.0002	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RBX1—urinary bladder cancer	0.000106	0.000199	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—HRAS—urinary bladder cancer	0.000105	0.000198	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PPARG—urinary bladder cancer	0.000105	0.000198	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—HRAS—urinary bladder cancer	0.000105	0.000197	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—KRAS—urinary bladder cancer	0.000105	0.000197	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—HRAS—urinary bladder cancer	0.000104	0.000197	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—HRAS—urinary bladder cancer	0.000104	0.000196	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—urinary bladder cancer	0.000104	0.000196	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—HRAS—urinary bladder cancer	0.000104	0.000195	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ENO2—urinary bladder cancer	0.000103	0.000194	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—urinary bladder cancer	0.000102	0.000193	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—CDKN1A—urinary bladder cancer	0.000102	0.000192	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—KRAS—urinary bladder cancer	0.000102	0.000192	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—EGFR—urinary bladder cancer	0.000102	0.000192	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PTEN—urinary bladder cancer	0.000102	0.000192	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—urinary bladder cancer	0.000102	0.000192	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—CREBBP—urinary bladder cancer	0.000101	0.00019	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—urinary bladder cancer	0.0001	0.000189	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.0001	0.000189	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	9.99e-05	0.000188	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL2—urinary bladder cancer	9.99e-05	0.000188	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GLI1—urinary bladder cancer	9.96e-05	0.000188	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MMP9—urinary bladder cancer	9.78e-05	0.000184	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—urinary bladder cancer	9.77e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—urinary bladder cancer	9.76e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—urinary bladder cancer	9.76e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—urinary bladder cancer	9.76e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RBX1—urinary bladder cancer	9.75e-05	0.000184	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—urinary bladder cancer	9.67e-05	0.000182	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—urinary bladder cancer	9.65e-05	0.000182	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KRAS—urinary bladder cancer	9.64e-05	0.000181	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	9.6e-05	0.000181	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.6e-05	0.000181	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—urinary bladder cancer	9.6e-05	0.000181	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—urinary bladder cancer	9.59e-05	0.000181	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RBX1—urinary bladder cancer	9.58e-05	0.00018	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—FGFR3—urinary bladder cancer	9.56e-05	0.00018	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—urinary bladder cancer	9.55e-05	0.00018	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MMP9—urinary bladder cancer	9.54e-05	0.00018	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—SRC—urinary bladder cancer	9.45e-05	0.000178	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—urinary bladder cancer	9.45e-05	0.000178	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EP300—urinary bladder cancer	9.28e-05	0.000175	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—urinary bladder cancer	9.27e-05	0.000175	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—CDKN1A—urinary bladder cancer	9.26e-05	0.000174	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PTEN—urinary bladder cancer	9.24e-05	0.000174	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—FGFR3—urinary bladder cancer	9.18e-05	0.000173	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EP300—urinary bladder cancer	9.04e-05	0.00017	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	9.04e-05	0.00017	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GLI1—urinary bladder cancer	9.03e-05	0.00017	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—urinary bladder cancer	9.03e-05	0.00017	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—urinary bladder cancer	9.03e-05	0.00017	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—SRC—urinary bladder cancer	9.02e-05	0.00017	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—urinary bladder cancer	8.9e-05	0.000168	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—urinary bladder cancer	8.85e-05	0.000167	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—SRC—urinary bladder cancer	8.79e-05	0.000166	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—JAG1—urinary bladder cancer	8.73e-05	0.000164	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—urinary bladder cancer	8.67e-05	0.000163	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FGFR3—urinary bladder cancer	8.67e-05	0.000163	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	8.64e-05	0.000163	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—SRC—urinary bladder cancer	8.57e-05	0.000161	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—FGFR3—urinary bladder cancer	8.32e-05	0.000157	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—EGFR—urinary bladder cancer	8.28e-05	0.000156	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—urinary bladder cancer	8.27e-05	0.000156	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—urinary bladder cancer	8.19e-05	0.000154	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CREBBP—urinary bladder cancer	8.14e-05	0.000153	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNA2—urinary bladder cancer	8.1e-05	0.000152	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—KRAS—urinary bladder cancer	7.96e-05	0.00015	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EGFR—urinary bladder cancer	7.91e-05	0.000149	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KRAS—urinary bladder cancer	7.82e-05	0.000147	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	7.8e-05	0.000147	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDH1—urinary bladder cancer	7.76e-05	0.000146	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EGFR—urinary bladder cancer	7.71e-05	0.000145	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—S100B—urinary bladder cancer	7.66e-05	0.000144	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—urinary bladder cancer	7.53e-05	0.000142	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—EGFR—urinary bladder cancer	7.51e-05	0.000141	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—urinary bladder cancer	7.47e-05	0.000141	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CREBBP—urinary bladder cancer	7.38e-05	0.000139	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNA2—urinary bladder cancer	7.34e-05	0.000138	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—urinary bladder cancer	7.34e-05	0.000138	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—urinary bladder cancer	7.28e-05	0.000137	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	7.23e-05	0.000136	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	7.23e-05	0.000136	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTEN—urinary bladder cancer	7.22e-05	0.000136	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—urinary bladder cancer	7.21e-05	0.000136	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.21e-05	0.000136	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.18e-05	0.000135	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—urinary bladder cancer	7.09e-05	0.000134	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDH1—urinary bladder cancer	7.03e-05	0.000132	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	7.01e-05	0.000132	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—S100B—urinary bladder cancer	6.94e-05	0.000131	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.9e-05	0.00013	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—EP300—urinary bladder cancer	6.88e-05	0.00013	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RBX1—urinary bladder cancer	6.83e-05	0.000129	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—ERBB2—urinary bladder cancer	6.81e-05	0.000128	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	6.76e-05	0.000127	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—urinary bladder cancer	6.65e-05	0.000125	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.56e-05	0.000124	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—ERBB2—urinary bladder cancer	6.54e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TSC1—urinary bladder cancer	6.42e-05	0.000121	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NCOR1—urinary bladder cancer	6.36e-05	0.00012	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—urinary bladder cancer	6.35e-05	0.00012	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RBX1—urinary bladder cancer	6.19e-05	0.000117	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—urinary bladder cancer	6.19e-05	0.000117	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ERBB2—urinary bladder cancer	6.18e-05	0.000116	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	6.13e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JAG1—urinary bladder cancer	6.11e-05	0.000115	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—urinary bladder cancer	6.03e-05	0.000114	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERCC2—urinary bladder cancer	5.98e-05	0.000113	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—ERBB2—urinary bladder cancer	5.93e-05	0.000112	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	5.82e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CDKN1A—urinary bladder cancer	5.82e-05	0.00011	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TSC1—urinary bladder cancer	5.82e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PTEN—urinary bladder cancer	5.81e-05	0.000109	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.65e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTHFR—urinary bladder cancer	5.62e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TERT—urinary bladder cancer	5.6e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDKN1A—urinary bladder cancer	5.59e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PTEN—urinary bladder cancer	5.58e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FGFR3—urinary bladder cancer	5.57e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JAG1—urinary bladder cancer	5.54e-05	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EP300—urinary bladder cancer	5.54e-05	0.000104	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—SRC—urinary bladder cancer	5.39e-05	0.000101	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1A—urinary bladder cancer	5.28e-05	9.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTEN—urinary bladder cancer	5.27e-05	9.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SRC—urinary bladder cancer	5.17e-05	9.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGFR3—urinary bladder cancer	5.14e-05	9.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1A—urinary bladder cancer	5.07e-05	9.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—urinary bladder cancer	5.06e-05	9.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGFR3—urinary bladder cancer	5.05e-05	9.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EP300—urinary bladder cancer	5.02e-05	9.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—S100B—urinary bladder cancer	4.95e-05	9.32e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.93e-05	9.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—urinary bladder cancer	4.89e-05	9.2e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	4.86e-05	9.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CREBBP—urinary bladder cancer	4.74e-05	8.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—urinary bladder cancer	4.72e-05	8.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—urinary bladder cancer	4.7e-05	8.86e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.7e-05	8.85e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—urinary bladder cancer	4.69e-05	8.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—urinary bladder cancer	4.54e-05	8.54e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	4.52e-05	8.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—S100B—urinary bladder cancer	4.49e-05	8.45e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	4.46e-05	8.41e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	4.46e-05	8.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—urinary bladder cancer	4.46e-05	8.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NCOR1—urinary bladder cancer	4.45e-05	8.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CREBBP—urinary bladder cancer	4.38e-05	8.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CREBBP—urinary bladder cancer	4.3e-05	8.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—urinary bladder cancer	4.28e-05	8.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—urinary bladder cancer	4.28e-05	8.07e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	4.28e-05	8.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—urinary bladder cancer	4.27e-05	8.03e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	4.2e-05	7.9e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—urinary bladder cancer	4.11e-05	7.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—urinary bladder cancer	4.05e-05	7.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NCOR1—urinary bladder cancer	4.04e-05	7.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ERBB2—urinary bladder cancer	3.97e-05	7.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RHOA—urinary bladder cancer	3.96e-05	7.45e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	3.95e-05	7.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—urinary bladder cancer	3.92e-05	7.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—urinary bladder cancer	3.88e-05	7.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—urinary bladder cancer	3.79e-05	7.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERBB2—urinary bladder cancer	3.66e-05	6.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—urinary bladder cancer	3.64e-05	6.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR3—urinary bladder cancer	3.6e-05	6.78e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERBB2—urinary bladder cancer	3.6e-05	6.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—urinary bladder cancer	3.6e-05	6.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—urinary bladder cancer	3.58e-05	6.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—urinary bladder cancer	3.56e-05	6.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—urinary bladder cancer	3.5e-05	6.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—urinary bladder cancer	3.44e-05	6.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1A—urinary bladder cancer	3.39e-05	6.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—urinary bladder cancer	3.38e-05	6.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—urinary bladder cancer	3.3e-05	6.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR3—urinary bladder cancer	3.26e-05	6.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—urinary bladder cancer	3.26e-05	6.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EP300—urinary bladder cancer	3.23e-05	6.08e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	3.2e-05	6.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—urinary bladder cancer	3.17e-05	5.97e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—urinary bladder cancer	3.14e-05	5.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1A—urinary bladder cancer	3.13e-05	5.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—urinary bladder cancer	3.12e-05	5.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1A—urinary bladder cancer	3.08e-05	5.79e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	3.07e-05	5.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—urinary bladder cancer	3.07e-05	5.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CREBBP—urinary bladder cancer	3.06e-05	5.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1—urinary bladder cancer	3.03e-05	5.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EP300—urinary bladder cancer	2.98e-05	5.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EP300—urinary bladder cancer	2.93e-05	5.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—urinary bladder cancer	2.9e-05	5.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—urinary bladder cancer	2.85e-05	5.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CREBBP—urinary bladder cancer	2.78e-05	5.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RHOA—urinary bladder cancer	2.77e-05	5.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—urinary bladder cancer	2.75e-05	5.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1—urinary bladder cancer	2.74e-05	5.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—urinary bladder cancer	2.6e-05	4.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—urinary bladder cancer	2.6e-05	4.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB2—urinary bladder cancer	2.57e-05	4.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—urinary bladder cancer	2.54e-05	4.78e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	2.52e-05	4.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RHOA—urinary bladder cancer	2.51e-05	4.73e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—urinary bladder cancer	2.49e-05	4.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—urinary bladder cancer	2.43e-05	4.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—urinary bladder cancer	2.4e-05	4.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—urinary bladder cancer	2.36e-05	4.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB2—urinary bladder cancer	2.33e-05	4.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—urinary bladder cancer	2.33e-05	4.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—urinary bladder cancer	2.27e-05	4.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—urinary bladder cancer	2.21e-05	4.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—urinary bladder cancer	2.21e-05	4.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—urinary bladder cancer	2.2e-05	4.14e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	2.19e-05	4.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1A—urinary bladder cancer	2.19e-05	4.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—urinary bladder cancer	2.19e-05	4.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—urinary bladder cancer	2.11e-05	3.97e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—EP300—urinary bladder cancer	2.09e-05	3.94e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EP300—urinary bladder cancer	2.09e-05	3.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—urinary bladder cancer	2.06e-05	3.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—urinary bladder cancer	2.04e-05	3.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—urinary bladder cancer	2.03e-05	3.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—urinary bladder cancer	2e-05	3.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—urinary bladder cancer	2e-05	3.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1A—urinary bladder cancer	1.99e-05	3.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—urinary bladder cancer	1.98e-05	3.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EP300—urinary bladder cancer	1.89e-05	3.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—urinary bladder cancer	1.84e-05	3.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—urinary bladder cancer	1.82e-05	3.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—urinary bladder cancer	1.78e-05	3.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—urinary bladder cancer	1.68e-05	3.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—urinary bladder cancer	1.65e-05	3.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—urinary bladder cancer	1.61e-05	3.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—urinary bladder cancer	1.52e-05	2.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—urinary bladder cancer	1.49e-05	2.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—urinary bladder cancer	1.43e-05	2.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—urinary bladder cancer	1.35e-05	2.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—urinary bladder cancer	1.29e-05	2.44e-05	CbGpPWpGaD
